Understanding the metabolic and endocrine mechanisms behind obesity in companion animals -- and its systemic disease implications -- is essential for evidence-based nutritional medicine.
Adipose tissue is not merely a passive energy storage depot. It is an active endocrine organ that secretes a range of bioactive molecules collectively termed adipokines, including leptin, adiponectin, resistin, and tumor necrosis factor-alpha (TNF-alpha). In obese animals, dysregulation of adipokine secretion contributes to a chronic low-grade inflammatory state that underlies many obesity-associated comorbidities.
Leptin, secreted by adipocytes in proportion to fat mass, normally signals satiety to the hypothalamus via the JAK-STAT signaling pathway. In obese animals, chronic hyperleptinemia leads to leptin resistance -- a state in which the hypothalamus becomes desensitized to leptin's satiety signal, perpetuating hyperphagia and further weight gain. This creates a self-reinforcing cycle that makes weight loss physiologically difficult.
Obesity-associated inflammation impairs insulin signaling at the cellular level, primarily through TNF-alpha-mediated serine phosphorylation of insulin receptor substrate-1 (IRS-1), which inhibits downstream glucose transporter (GLUT4) translocation. In cats, this manifests as Type 2-like diabetes mellitus -- a condition that is strongly associated with obesity and may be reversible with weight loss in early stages.
Excess body weight increases mechanical loading on articular cartilage, accelerating degradation. Additionally, adipose-derived inflammatory mediators (particularly IL-6 and TNF-alpha) directly promote chondrocyte apoptosis and matrix metalloproteinase (MMP) activity, contributing to cartilage breakdown independent of mechanical effects. This explains why obese animals develop osteoarthritis even in non-weight-bearing joints.
Thoracic fat deposits reduce chest wall compliance and functional residual capacity, increasing the work of breathing. Obesity-associated hypertension results from increased circulating blood volume, sympathetic nervous system activation, and renin-angiotensin-aldosterone system (RAAS) upregulation by adipose tissue. These effects compound in anesthetic patients, significantly increasing perioperative risk.